Gilead Latin America & Caribbean Grants

Gilead Latin America & Caribbean Grants

Status: ACTIVE
Funder: Gilead Sciences, Inc.
Last Updated: September 25, 2025

Summary

Gilead Latin America & Caribbean Grants support community-driven healthcare initiatives aimed at vulnerable populations. The grants prioritize innovative projects in HIV, liver diseases, and oncology, focusing on improving healthcare access and reducing disparities. Applications are accepted year-round, with an emphasis on partnerships with local nonprofits and healthcare advocates. Gilead aims to foster health equity and education, ensuring effective outcomes for the communities it serves.

Overview

NOTE: Grant applications are accepted throughout the year. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review. What We Fund We support community-informed, data-driven programs that strengthen healthcare infrastructures and provide education and financial support to the most vulnerable communities around the world. Our corporate giving programs focus support where the need is greatest and we prioritize applications that demonstrate a strong capability to deliver the specific outcomes the grant would support. We welcome funding requests for innovative, high-impact projects that relate to at least one of our core therapeutic areas: HIV Liver disease Hepatitis CHepatitis BHepatitis DPrimary biliary cholangitisOncologyHematologySolid tumorsChronic Inflammatory Diseases Types of Support Patient Community Support: We strive to advance health equity, diversity in clinical trials and access to medicines to reduce disparities. We also support the local communities in which we operate. Examples of Patient Community Support projects Gilead has funded include:Events or resources to educate patients about prevention and care options, such as:PresentationsWeb-based resourcesPrinted materialsTesting and screening initiativesThe types of Patient Community Support organizations Gilead has funded include:Patient advocacy and support groupsHospitals and clinicsNonprofit service organizationsProfessional associationsAcademic medical centers and universities Corporate Sponsorships: Many individuals face barriers to accessing healthcare due to age, disability, ethnicity or race, location, gender, gender identity or socioeconomic status. To help ensure all people have the opportunity to get the best possible care – regardless of background – Gilead sponsors select events or conferences that raise awareness and support organizations working in our therapeutic areas of focus. Events Gilead has sponsored include: Walks/runs Awards dinners Fundraising galas Community conferences Note: If you are seeking funding for a local event exhibit or display that will appear at a local program, please contact your local Gilead field sales employee. Gilead Latin America & Caribbean Grants For years, Gilead has worked with local partners to provide our medicines throughout Latin America and the Caribbean. Our efforts focus on addressing unmet medical needs in the region, bringing innovative treatments to communities in Argentina, Belize, Brazil, Haiti, Jamaica and beyond. Following our mission to create a healthier world for all people, we identify and support organizations that seek to: Improve access to healthcare Reduce disparities for disadvantaged groups Advance education among patients and healthcare professionals Support local communities Funding Priorities HIV-AIDSWe’re committed to ending the HIV epidemic in Latin America and the Caribbean. Numerous factors are driving the epidemic in this region. The social stigma of HIV-positive status leads many to decline treatment or travel great distances to be treated outside their community. Elsewhere, poor treatment options for incarcerated populations (a group that faces systemic barriers to receiving quality HIV care) leads to public health concerns as individuals complete their rehabilitation programs and re-enter society.We support organizations working to help individuals learn their HIV status and get the care they need. We also fund local groups looking to meet the unique needs of the region, including:Increasing awareness and understanding of HIV incidence and treatment methods Facilitating medicine provision and local provider expertise Supporting linkage to care programs Identifying and fostering prevention programs for at-risk individuals, including via pre-exposure prophylaxis (PrEP)Liver Disease:In Latin America and the Caribbean, many people are living with undiagnosed hepatitis C, driven in part by a lack of disease awareness and diagnosis options have contributed to the persistence of this gap. Our grantee partners seek to increase awareness of risk factors and the educational tools available to patient communities throughout the region. We also fund projects to improve diagnostics and build medical specialization in hepatitis B (HBV) and HCV.We are working to improve the overall continuum of care for liver diseases by funding organizations that:Ensure providers have the training and expertise they need to deliver proper care Improve infrastructure and screening ability of regions where care is dependent on viral load Reduce undiagnosed totals Increase awareness of risk factorsOther Opportunities:Though priority is given to projects that address HIV and liver disease, we consider grant proposals outside of these therapeutic areas, provided they conform to our eligibility restrictions. These proposals may include (but are not limited to):Access and education surrounding antifungal treatments Social services (homeless shelters, food banks, etc.) Community vibrancy projects (STEM education, arts support, community beautification, etc.)

Eligibility

You can learn more about this opportunity by visiting the funder's website. We work with patient advocates, nonprofits, and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement. Only tax exempt nonprofits are eligible. Grant funding is primarily awarded for direct programmatic support.

Ineligibility

Grants may not be provided:To pay for patient care, treatment and/or prescriptions To pay for general operating expenses or purchase of standard equipment or hardware at institutions in a position to influence, purchase or prescribe a Gilead product To support a healthcare practitioner’s expenses for attendance or travel to educational programs To individual healthcare professionals or for-profit physician group practices To pay honoraria of healthcare providers employed by or affiliated with the requesting organization To pay for advertising or creation of advertising materials related to a Gilead product To pay for development or production of promotional items related to any Gilead product To support the costs of government lobbying activities To compensate individuals who provide services to Gilead, such as speaking or advising To serve in lieu of a discount or price concession or as part of a contract negotiation To support clinical studiesGilead generally does not provide grant support for indirect costs of an organization or activity. Gilead does not provide retroactive funding.